Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study

The anti-inflammatory effects of oral theophylline on cells in bronchial biopsies of symptomatic atopic asthmatic subjects were investigated. Following a 2 week run-in period, asthmatic subjects were randomly assigned to either placebo (n=11) or theophylline (n=15). Bronchial biopsies were taken at fibre-optic bronchoscopy at the beginning and end of a 6 week period, during which subjects took placebo or theophylline medication at a dose intended to produce therapeutic concentrations. Nine of the placebo subjects and 12 of the theophylline subjects completed the study. Improvement in asthma control was seen in the theophylline-treated group. The mean (SD) theophylline blood level at the end of the study was 10.9 (6.0) microg x mL-1. A significant decrease in interleukin (IL)4 expression from 1.38 to 1.04 cells x mm-2 (<0.05) and a trend to a reduction in IL-5 from 1.29 to 0.48 cells x mm-2 (NS) were seen in biopsies from the theophylline-treated group compared with placebo, although there was no change in mast cell numbers (judged by tryptase expression). A decrease in epithelial CD8+ cells from 2.60 to 0.53 cells x mm-1 of surface (<0.05) was noted. This study shows an anti-inflammatory effect of theophylline in asthmatic bronchi, both in cell numbers and in the expression of IL-4, believed to be an important cytokine in the pathophysiology of asthmatic inflammation. We speculate that theophylline induces downregulation in vivo of cytokine production, accounting for the known inhibitory effect of theophylline on the late asthmatic reaction.

This article has been cited by other articles:

				K. Ito, S. Lim, G. Caramori, B. Cosio, K. F. Chung, I. M. Adcock, and P. J. Barnes A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression PNAS, June 25, 2002; 99(13): 8921 - 8926. [Abstract] [Full Text] [PDF]

				J C Kips and R A Pauwels Low dose inhaled corticosteroids and the prevention of death from asthma Thorax, September 1, 2001; 56(90002): ii74 - 78. [Full Text] [PDF]

				S. LIM, K. TOMITA, G. CARRAMORI, A. JATAKANON, B. OLIVER, A. KELLER, I. ADCOCK, K. F. CHUNG, and P. J. BARNES Low-dose Theophylline Reduces Eosinophilic Inflammation but Not Exhaled Nitric Oxide in Mild Asthma Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 273 - 276. [Abstract] [Full Text] [PDF]

				S. Lim, A. Jatakanon, D. Gordon, C. Macdonald, K. F. Chung, and P. J Barnes Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice Thorax, October 1, 2000; 55(10): 837 - 841. [Abstract] [Full Text]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				A. WALLIN, T. SANDSTRÖM, M. SÖDERBERG, P. HOWARTH, B. LUNDBÄCK, G. DELLA-CIOPPA, S. WILSON, M. JUDD, S. HOLGATE, A. LINDBERG, et al. The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 79 - 86. [Abstract] [Full Text]